Startup drugmaker Genzada Pharmaceuticals said it will build new headquarters in Sterling, KS, and renovate an existing building to house a “small-scale” manufacturing facility and R&D facility.
The company said it expects to create as many as 25 to 30 new jobs in the south-central Kansas town. The expansion for the headquarters is expected to be 10,000-square feet and be completed sometime next year, KWCH12 reported.
"The new space will allow us to continue to expand on achieving our mission, which is to eliminate diseases that induce human suffering,” Jason West, Genzada’s EVP, told the television station.
The company plans to seek FDA approval next year for human testing of various pharmaceutical products for rare and hard-to-treat cancers and other medical conditions.
Genzada has conducted studies with a combination of three chemical compounds, including a pair from plant-based material, West said.
-here’s the KWCH12 story